🔗 Permalink

Inventor profile of:

Balasingam Radhakrishnan

City:

Chapel Hill, North Carolina

Country:

United States

Published Applications:

Last publication date:

2025-08-28

Top Assignees for applications by Balasingam Radhakrishnan

The entities that hold a legal rights for patent applications filed by inventor Radhakrishnan Balasingam:

Biocon Limited 14 , India
Cidara Therapeutics, Inc. 9 San Diego, CA United States
RESQ Pharmaceuticals LLC 5 Orange, CA United States
Seachaid Pharmaceuticals, Inc. 3 Durham, NC United States
NOBEX CORPORATION 3 Durham, NC United States
NAPP PHARMACEUTICAL GROUP LIMITED 2 CAMBRIDGE, United Kingdom
Biocon Ltd. 1 , India
BIOCON LIMITED 1 Electronic, India
Seachaid Pharmaceuticals, Inc. 1 Mebane, NC United States

Recent patent applications by Radhakrishnan Balasingam

Balasingam Radhakrishnan from Chapel Hill, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2025-08-28

US20250268853A1

Human necessities

METHODS AND COMPOSITIONS FOR TREATING EDEMA REFRACTORY TO ORAL DIURETICS

#2 | 2025-01-30

US20250032436A1

Human necessities

METHODS AND COMPOSITIONS FOR TREATING EDEMA REFRACTORY TO ORAL DIURETICS

#3 | 2024-08-29

US20240285566A1

Human necessities

SUBCUTANEOUS FORMULATION AND METHODS FOR TREATING EDEMA REFRACTORY TO ORAL DIURETICS

#4 | 2023-11-16

US20230365629A1

Chemistry; metallurgy

Synthesis of echinocandin antifungal agent

#5 | 2022-10-13

US20220323539A1

Human necessities

Compositions and methods for the treatment of fungal infections

#6 | 2022-09-15

US20220287996A1

Human necessities

Methods and compositions for treating edema refractory to oral diuretics

#7 | 2022-05-26

US20220162263A1

Chemistry; metallurgy

ANTIFUNGAL AGENTS AND USES THEREOF

#8 | 2022-03-01

US17345550

Human necessities

Methods and compositions for treating edema refractory to oral diuretics

#9 | 2021-06-17

US20210179667A1

Chemistry; metallurgy

Synthesis of echinocandin antifungal agent

#10 | 2021-06-10

US20210169833A1

Human necessities

Methods and compositions for treating edema refractory to oral diuretics

#11 | 2021-05-06

US20210128670A1

Human necessities

Dosing regimens for echinocandin class compounds

#12 | 2020-08-27

US20200268833A1

Human necessities

Compositions and methods for the treatment of fungal infections

#13 | 2019-05-30

US20190160141A1

Human necessities

Dosing regimens for echinocandin class compounds

#14 | 2017-09-07

US20170253635A1

Chemistry; metallurgy

ANTIFUNGAL AGENTS AND USES THEREOF

#15 | 2017-06-01

US20170151306A1

Human necessities

Dosing regimens for echinocandin class compounds

#16 | 2016-03-17

US20160075740A1

Chemistry; metallurgy

Antifungal agents and uses thereof

#17 | 2016-03-17

US20160074322A1

Human necessities

ORAL CEFEPIME COMPOSITIONS AND USES THEREOF

#18 | 2015-03-26

US20150087583A1

Human necessities

Dosing regimens for echinocandin class compounds

#19 | 2015-01-22

US20150024997A1

Chemistry; metallurgy

Antifungal agents and uses thereof

#20 | 2014-11-06

US20140329793A1

Human necessities

Pharmaceutical compositions and uses thereof

#21 | 2014-06-19

US20140171357A1

Chemistry; metallurgy

VANCOMYCIN DERIVATIVES

#22 | 2011-05-26

US20110124553A1

Chemistry; metallurgy

Insulin-oligomer conjugates, formulations and uses thereof

#23 | 2011-05-19

US20110118179A1

Chemistry; metallurgy

Cation complexes of insulin compound conjugates, formulations and uses thereof

#24 | 2010-05-11

US10166355

Calcitonin drug-oligomer conjugates, and uses thereof

#25 | 2010-04-29

US20100105624A1

Chemistry; metallurgy

Calcitonin drug-oligomer conjugates, and uses thereof

#26 | 2010-04-29

US20100105605A1

Chemistry; metallurgy

Fatty acid formulations and oral delivery of proteins and peptides, and uses thereof

#27 | 2010-02-16

US10723933

Natriuretic compounds, conjugates, and uses thereof

#28 | 2007-12-25

US10389499

Insulin polypeptide-oligomer conjugates, proinsulin polypeptide-oligomer conjugates and methods of synthesizing same

#29 | 2007-01-23

US10382022

Insulin polypeptide-oligomer conjugates, proinsulin polypeptide-oligomer conjugates and methods of synthesizing same

#30 | 2006-12-28

US20060293219A1

Chemistry; metallurgy

Methods of treating diabetes mellitus

#31 | 2006-09-07

US20060199759A1

Human necessities

Mixtures of insulin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same

#32 | 2006-08-01

US10835018

Mixtures of insulin drug-oligomer comprising polyalkylene glycol

#33 | 2006-05-11

US20060100137A1

Chemistry; metallurgy

Insulin conjugates for treating diabetes mellitus

#34 | 2006-01-26

US20060019874A1

Chemistry; metallurgy

Cation complexes of insulin compound conjugates, formulation and uses thereof

#35 | 2006-01-26

US20060019873A1

Chemistry; metallurgy

Insulin-oligomer conjugates, formulations and uses thereof

#36 | 2006-01-26

US20060018874A1

Chemistry; metallurgy

Fatty acid formulations for oral delivery of proteins and peptides, and uses thereof

#37 | 2005-12-15

US20050277580A1

Chemistry; metallurgy

Methods of synthesizing insulin polypeptide-oligomer conjugates, and proinsulin polypeptide-oligomer conjugates and methods of synthesizing same

#38 | 2005-08-16

US10716975

Methods of activating a receptor using amphiphilic drug-oligomer conjugates

#39 | 2005-07-05

US10036744

Methods of synthesizing insulin polypeptide-oligomer conjugates, and proinsulin polypeptide-oligomer conjugates and methods of synthesizing same

#40 | 2005-04-14

US20050080001A1

Chemistry; metallurgy

Proinsulin polypeptide-oligomer conjugates

InventorID:

806672 ⎘